ºù«Ӱҵ

All publications

Journal articles

• Pennington B, Hernández Alava M & Strong M (2024) . PharmacoEconomics, 1-14.
• Meier PS, Holmes J, Stevely A, Boyd JE, Alava MH, Hardie I, Warde A & Sasso A (2024) . Drug and Alcohol Review.
• Maslyankov I & Hernández M (2024) . PLOS ONE, 19(10), e0312475-e0312475.
• Squires H, Kelly MP, Gilbert N, Sniehotta F, Purshouse RC, Garcia L, Breeze P, Brennan A, Gardner B, Bright S , Fischer A et al (2024) . BMC Public Health, 24(1).
• Pennington BM, Alava MH & Strong M (2024) . Value in Health.
• Holmes J, Sasso A, Hernández Alava M, Borges Neves R, Stevely AK, Warde A & Meier PS (2024) . International Journal of Drug Policy, 127.
• Hnynn Si PE, Hernández-Alava M, Dunn L, Wilkie M & Fotheringham J (2023) . BMC Nephrology, 24(1).
• Holmes J, Sasso A, Hernández Alava M, Stevely AK, Warde A, Angus C & Meier PS (2023) . SSM - Population Health.
• Stevely AK, Mackay D, Alava MH, Brennan A, Meier PS, Sasso A & Holmes J (2023) . Public Health, 220, 43-49.
• Si PEH, Hernandez M, Sasso A, Gittus M, Powell R, Dunn L & Fotheringham J (2023) . Nephrology Dialysis Transplantation, 38(Supplement_1).
• Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M , Gilbert N et al (2023) . Health Economics.
• Bowen JM, Hernandez M, Johnson DS, Green C, Kammin T, Baker D, Keigwin S, Makino S, Taylor N, Watson O , Wheeldon NM et al (2023) . European Journal of Human Genetics.
• Warde A, Sasso A, Holmes J, Hernandez Alava M, Stevely A & Meier P (2023) . Nordic Studies on Alcohol and Drugs.
• Tappenden P, Navega Biz A, Hernández Alava M, Sasso A, Sutton L, Ennis K, Elliott R & Wildman M (2023) . International Journal of Technology Assessment in Health Care, 39(1).
• Hernández Alava M, Pudney S & Wailoo A (2023) . PharmacoEconomics, 41(2), 199-207.
• Gray LA, Hernandez Alava M & Wailoo AJ (2022) . BMC Cancer, 22(1).
• Holmes J, Sasso A, Alava MH, Neves RB, Stevely AK, Warde A & Meier PS (2022) . Lancet, 400 Suppl 1, S50.
• Sasso A, Hernández-Alava M, Holmes J, Field M, Angus C & Meier P (2022) . Social Science & Medicine, 310.
• Hernandez M & Pudney S (2022) . Health Economics.
• Wildman MJ, O’Cathain A, Hind D, Maguire C, Arden MA, Hutchings M, Bradley J, Walters SJ, Whelan P, Ainsworth J , Tappenden P et al (2021) . Programme Grants for Applied Research, 9(11), 1-146.
• Opazo Breton M, Gillespie D, Pryce R, Bogdanovica I, Angus C, Hernandez Alava M, Brennan A & Britton J (2021) . Addiction.
• Wailoo A, Alava MH, Pudney S, Barton G, O’Dwyer J, Gomes M, Irvine L, Meads D & Sadique Z (2021) . Value in Health, 24(4), 568-574.
• Pennington BM, Hernández-Alava M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J (2020) . Value in Health.
• Hernandez Alava M, Pudney S & Wailoo A (2020) . Value in Health.
• Kiadaliri A, Alava MH, Roos EM & Englund M (2019) . Quality of Life Research.
• Gray LA, Wailoo A & Hernandez M (2018) . Value in Health.
• Pennington B, Hernandez-Alava M, Pudney S & Wailoo A (2018) . PharmacoEconomics.
• Hernandez M & pudney S (2018) EQ5DMAP: a command for mapping between EQ-5D-3L and EQ-5D-5L. The Stata journal, 18(2), 395-415.
• Gray LA, Hernandez M & Wailoo AJ (2018) . Value in Health, 21(6), 748-757.
• Gray LA, Hernandez M, Kelly M & Campbell M (2018) . BMC Public Health, 18, 500-500.
• Gray LA & Alava MH (2018) . The Stata Journal: Promoting communications on statistics and Stata, 18(1), 51-75.
• Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G & Irvine L (2018) . Value in Health, 21(1), 49-56.
• Gibson LA, Hernandez M, Kelly M & Campbell M (2017) . Journal of Public Health, 39(4), e152-e160.
• Hernandez-Alava M & Pudney S (2017) . Journal of Health Economics, 55, 139-152.
• Stevenson MD, Wailoo AJ, Tosh JC, Hernandez-Alava M, Gibson LA, Stevens JW, Archer RJ, Simpson EL, Hock ES, Young A & Scott DL (2017) . Journal of Rheumatology, 44(7), 973-980.
• Hernandez-Alava M & Popli G (2017) . Demography, 54(2), 485-511.
• Mukuria C, Rowen D, Hernández-Alava M, Dixon S & Ara R (2017) . Applied Health Economics and Health Policy.
• Wailoo AJ, hernandez M, manca A, mejia A, Ray J, crawford B, botteman M & busschbach J (2017) . Value in Health, 20(1), 18-27.
• Ward Fuller G, Hernandez M, Pallot D, Lecky F, Stevenson M & Gabbe B (2017) . Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 20(1), 141-151.
• Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) . Health Technology Assessment, 20(35), 611-614.
• Rowen D, Dixon S, Hernández-Alava M & Mukuria C (2016) . The European Journal of Health Economics, 17(6), 733-744.
• Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) . Health Technology Assessment, 20(35), 1-610.
• Hernandez M & Pudney S (2016) . The Stata Journal, 16(1), 159-184.
• Wailoo A, Hernández M, Philips C, Brophy S & Siebert S (2015) . Value in Health, 18(4), 425-431.
• Alava MH & Wailoo A (2015) . The Stata Journal: Promoting communications on statistics and Stata, 15(3), 737-750.
• Wailoo A, Hernandez Alava M, Scott IC, Ibrahim F & Scott D (2014) . Rheumatology, 53(10), 1773-1777.
• Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2014) . Med Decis Making, 34(7), 919-930.
• Wailoo A, Hernandez Alava M & Escobar Martinez A (2014) . Health Qual Life Outcomes, 12, 37.
• Stevenson M, Gomersall T, Lloyd Jones M, Rawdin A, Hernández M, Dias S, Wilson D & Rees A (2014) . Health Technol Assess, 18(17), 1-290.
• Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P , Devianee Keetharuth A et al (2014) . Health Technol Assess, 18(9), 1-224.
• Wailoo AJ, Hernandez M & Escobar Martinez A (2013) . VALUE IN HEALTH, 16(7), A606-A606.
• Kearns B, Ara R, Wailoo A, Manca A, Alava MH, Abrams K & Campbell M (2013) . Pharmacoeconomics, 31(8), 643-652.
• Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2013) . Rheumatology (Oxford), 52(5), 944-950.
• Alava MH, Brazier J, Rowen D & Tsuchiya A (2013) . Med Decis Making, 33(6), 839-852.
• Hernández Alava M, Wailoo AJ & Ara R (2012) . Value Health, 15(3), 550-561.
• Ara R, Blake L, Gray L, Hernández M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M , Abrams K et al (2012) . Health Technol Assess, 16(5), iii-195.
• Rowen D, Brazier J, Tsuchiya A & Alava MH (2012) . Health Economics, 21(6), 715-729.
• Wailoo AJ, Hernandez M & Ara R (2011) . VALUE IN HEALTH, 14(7), A242-A242.
• Wailoo A, Goodacre S, Sampson F, Alava MH, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder M & Gray H (2010) . Heart, 96(9), 668-672.
• Hernandez M, Pudney S & Hancock R (2007) . J APPL ECONOM, 22(3), 581-598.
• Hernandez M & Pudney S (2007) . J PUBLIC ECON, 91(1-2), 327-341.
• Hancock R, Pudney S, Barker G, Hernandez M & Sutherland H (2004) . Fiscal Studies, 25(3), 279-303.
• Hernández M (2002) . Contributions to Economics, 19-36.
• Wilson L, Bain M, Hernandez M, Holmes J, Pryce R, Sasso A, Stevely A, Warde A & Meier P () Solitary drinkers in Great Britain: How do their sociodemographic characteristics, consumption patterns, and drinking occasions differ from those who drink with others?. Journal of Studies on Alcohol and Drugs.
• Hernandez Alava M, Sasso A, Hnynn Si PE, Gittus M, Powell R, Dunn L, Thokala P & Fotheringham J () . Acta Dermato-Venereologica, 103, adv11604-adv11604.
• Falk Hvidberg M & Hernández Alava M () . PharmacoEconomics.
• Franklin M & Hernández Alava M () . Quality of Life Research.
• Hernández Alava M, Pudney SE & Wailoo AJ () . Value in Health.
• Thokala P, Hnynn Si PE, Hernandez Alava M, Sasso A, Schaufler T, Soro M & Fotheringham J () . PharmacoEconomics.
• Hvidberg M, Hernandez M, Petersen K, Davidsen M, Witt Udsen F, Frølich A & Ehlers L () . MDM Policy & Practice.
• Hernández Alava M, Wailoo A, Pudney S, Gray L & Manca A () . Health Technology Assessment, 24(34), 1-68.
• Gray L, Hernandez M & Wailoo A () Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer. BMC Cancer.
• Poku E, Harnan S, Rooney G, James MM-S, Hernandez M, Schaufler T, Thokala P & Fotheringham J () . Clinical Kidney Journal.
• Wailoo A, Hernandez M, Chrysanthou G, Barcelos F, van Gaalen F, Santos H, Fagerli K, Gago L, Margarida Cunha M, van de Sande M , Couto M et al () MEASURING QUALITY OF LIFE OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS FOR ECONOMIC EVALUATION. RMD Open.

Chapters

• Hernandez M (2019) In Hamilton J (Ed.), Oxford Research Encyclopedia of Economics and Finance. OUP

Conference proceedings papers

• Thokala P, Si PEH, Hernandez M, Sasso A, Schaufler T, Soro M & Fotheringham J (2024) Cost-Effectiveness of Difelikefalin compared to Standard Care for treating Chronic Kidney Disease Associated Pruritus (CKD-aP). MEDICAL DECISION MAKING, Vol. 44(2) (pp NP160-NP160)
• Stevely A, Holmes J, Sasso A, Alava MH, Warde A, Angus C & Meier P (2023) . SSM Annual Scientific Meeting
• Si PEH, Hernandez M, Sasso A, Gittus M, Powell R, Dunn L & Fotheringham J (2023) CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 38 (pp I760-I760)
• Franklin M, Porter A, de Vocht F, Kearns B, Latimer N, Hernandez M, Young T & Kidger J (2023) COMBINING CAUSAL INFERENCE AND WITHIN-TRIAL ECONOMIC EVALUATION METHODS TO ASSESS THE COST-EFFECTIVENESS OF A MENTAL HEALTH SERVICE USING REAL-WORLD DATA: THE QUASI-EXPERIMENTAL ADAPT STUDY. VALUE IN HEALTH, Vol. 26(12) (pp S87-S87)
• Geue C, Hawkins N, Oakley JE, Grieve R, Hernandez M & Carpenter J (2022) A FRAMEWORK FOR EXPERT ELICITATION RELATED TO COUNTERFACTUAL VALUES: A CASE STUDY OF ELICITATION TO INFORM SUBGROUP ANALYSES IN CLINICAL TRIALS. VALUE IN HEALTH, Vol. 25(1) (pp S274-S274)
• Si PEH, Hernandez M, Dunn L, Wilkie M & Fotheringham J (2022) SYMPTOM IMPROVEMENT WITH STANDARD CARE IN PEOPLE RECEIVING HAEMODIALYSIS ACROSS A RANGE OF SYMPTOMS IN THE POS-S RENAL: CONSIDERATION FOR CLINICAL PRACTICE AND TRIAL DESIGN. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 37 (pp I619-I620)
• Geue C, Hawkins N, Oakley J, Grieve R, Hernandez M & Carpenter J (2020) A FRAMEWORK FOR EXPERT ELICITATION TO INFORM SUBGROUP ANALYSES IN CLINICAL TRIALS. MEDICAL DECISION MAKING, Vol. 40(5) (pp E410-E411)
• Hawkins N, Geue C, Oakley J, Grieve R & Hernandez M (2020) AN EXPLORATION OF THE TRADE-OFF BETWEEN FALSE NEGATIVES AND FALSE POSITIVES WHEN IDENTIFYING SUBGROUP EFFECTS. MEDICAL DECISION MAKING, Vol. 40(1) (pp E266-E267)
• Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernández M (2019) . Value in Health, Vol. 22(Suppl. 3) (pp S891-S891). Copenhagen, Denmark, 2 November 2019 - 6 November 2019.
• Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernandez M (2019) MAPPING FROM VISUAL ACUITY TO UTILITY IN PATIENTS WITH MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION USING DATA FROM THE LEAVO TRIAL. VALUE IN HEALTH, Vol. 22 (pp S891-S891)
• Wailoo AJ, Stevenson M, Tosh J, Hernández M, Stevens JW, Archer R, Simpson E, everson HE, Scott D, Young A , Paisley S et al (2014) . Value in Health, Vol. 17(7) (pp a380)

Reports

• Hernandez M & Pudney SE (2016) Copula-based modelling of self-reported health states: An application to the use of EQ-5D-3L and EQ-5D-5L in evaluating drug therapies for rheumatic disease

Scholarly editions

• Rowen D, Brazier J, Tsuchiya A, Hernández M & Ibbotson R (2009) The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results.

Posters

• Geue C, Hawkins N, Oakley JE, Grieve R, Hernandez M & Carpenter J (2022) POSB421 A Framework for Expert Elicitation Related to Counterfactual Values: A Case Study of Elicitation to Inform Subgroup Analyses in Clinical Trials..
• Mukuria C, Dixon S, Rowen D & Hernandez M Examining productivity losses associated with health related quality of life using patient data (2014).

Working papers

• Hernandez M & Pudney S () What you don't see can't hurt you? Panel data analysis and the dynamics of unobservable factors.
• Hernandez M, Pudney S & Hancock R () The welfare cost of means-testing: pensioner participation in income support.
• Pudney S, Hernandez M & Hancock R () The Welfare Cost of Means-Testing: Pensioner Participation in Income Support.
• Pudney S, Hernandez M & Hancock R () The Welfare Cost of Means-Testing: Pensioner Participation in Income Support.

Datasets

• Pennington R, Hernandez M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J .

Presentations

• Hernandez M, Wailoo A, Chrysanthou G, Carvalho P, Van der Heijde D, Santos MJ & Machado PM .

Preprints

• Worboys HM, Gray LJ, Burton JO, Alava MH & Cooper NJ (2023) , Research Square Platform LLC.
• Franklin M, Porter A, De Vocht F, Kearns B, Latimer N, Alava MH, Young T & Kidger J (2023) .
• Holmes J, Sasso A, Alava MH, Neves RB, Stevely AK, Warde A & Meier PS (2023) , Cold Spring Harbor Laboratory.